Imdur and Valcyte drug interactions - a phase IV clinical study of FDA data
Summary:
Drug interactions are reported among people who take Imdur (isosorbide mononitrate) and Valcyte (valganciclovir hydrochloride). Common drug interactions include diabetic nephropathy among females and blood creatinine increased among males.
The phase IV clinical study analyzes what interactions people have when they take Imdur and Valcyte. It is created by eHealthMe based on reports of 27 people who take the same drugs from the FDA, and is updated regularly.
What is Imdur?
Imdur has active ingredients of isosorbide mononitrate. It is often used in angina. eHealthMe is studying from 17,367 Imdur users. Check the latest studies of Imdur.
What is Valcyte?
Valcyte has active ingredients of valganciclovir hydrochloride. It is often used in cmv - immunocompromised host. eHealthMe is studying from 6,409 Valcyte users. Check the latest studies of Valcyte.
27 people who take Imdur and Valcyte together, and have interactions are studied.

What are the common drug interactions of Imdur and Valcyte, by gender? *:
female:
- Diabetic nephropathy (diabetic kidney disease)
- Diarrhoea
- Dyspnoea (difficult or laboured respiration)
- Ejection fraction decreased (systolic heart failure)
- Heart transplant
- Hyperparathyroidism secondary (an abnormally high concentration of parathyroid hormone in the blood, resulting in weakening of the bones through loss of calcium-secondary)
- Influenza
- Mitral valve incompetence (inefficient heart valve)
- Nephrogenic anaemia (anaemia due to kidney disease)
- Nephropathy toxic (damage to kidney due to toxins)
male:
- Blood creatinine increased
- Sepsis (a severe blood infection that can lead to organ failure and death)
- Nephropathy toxic (damage to kidney due to toxins)
- Renal failure (kidney dysfunction)
- Adrenal insufficiency (a condition in which the adrenal glands do not produce adequate amounts of steroids)
- Asthenia (weakness)
- Blood glucose increased
- Cerebrovascular accident (sudden death of some brain cells due to lack of oxygen when the blood flow to the brain is impaired by blockage or rupture)
- Chronic kidney disease
- Dehydration (dryness resulting from the removal of water)
What are the common drug interactions of Imdur and Valcyte, by age (0-1 to 60+)? *:
0-1:
n/a
2-9:
n/a
10-19:
n/a
20-29:
- Acute pulmonary oedema (sudden deposit of fluid in the lung))
- Diarrhoea
30-39:
n/a
40-49:
- Diabetes mellitus (diabetes, caused by a deficiency of the pancreatic hormone insulin)
- Diabetic nephropathy (diabetic kidney disease)
- Nephropathy toxic (damage to kidney due to toxins)
- Ophthalmoplegia (a paralysis or weakness of one or more of the muscles that control eye movement)
- Renal transplant
50-59:
- Influenza
- Malaise (a feeling of general discomfort or uneasiness)
- Oliguria (not enough urine)
- Pneumonia
- Pseudomonas infection (pseudomonas infection is caused by a bacterium, pseudomonas aeruginosa)
- Pyrexia (fever)
- Renal injury (kidney injury)
- Renal transplant
- Sinus bradycardia (an unusually slow heartbeat due to heart disease)
- Transplant rejection (a transplant material is not worked)
60+:
- Cardiac failure congestive
- Acute prerenal failure (prerenal acute renal failure (arf) occurs when a sudden reduction in blood flow to the kidney)
- Bundle branch block left (absence of transmission of electric impulses from the atrioventricular (av) bundle of his to the left ventricle)
- Bundle branch block right (absence of transmission of electric impulses from the atrioventricular (av) bundle of his to the right ventricle)
- Cardiomegaly (increased size of heart than normal)
- Dialysis disequilibrium syndrome (central nervous system disorder)
- Dyspnoea (difficult or laboured respiration)
- Electrolyte imbalance
- Fluid overload (too much fluid in the blood)
- Haematocrit decreased
What are the existing conditions these people have? *
- Immunodeficiency Disorders: 8 people, 29.63%
- High Blood Pressure: 5 people, 18.52%
- Gastroesophageal Reflux Disease (a condition in which stomach contents leak backward from the stomach into the oesophagus): 3 people, 11.11%
- Cardiac Disorder: 3 people, 11.11%
- Stable Angina (a constant chest pain): 2 people, 7.41%
- Pain: 2 people, 7.41%
- Nausea (feeling of having an urge to vomit): 2 people, 7.41%
- Latent Tuberculosis (hidden tuberculosis): 2 people, 7.41%
- Insomnia (sleeplessness): 2 people, 7.41%
- Hyperlipidaemia (presence of excess lipids in the blood): 2 people, 7.41%
* Approximation only. Some reports may have incomplete information.
Do you take Imdur and Valcyte?
- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously
Related studies:
Effectiveness of, side effects of, and alternative drugs to the 2 drugs:
Browse all drug interactions of Imdur and Valcyte:
a b c d e f g h i j k l m n o p q r s t u v w x y zSub-studies by gender and age:
Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+
Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+
Browse all side effects of Imdur:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all side effects of Valcyte:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all interactions between Imdur and drugs from A to Z:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all interactions between Valcyte and drugs from A to Z:
a b c d e f g h i j k l m n o p q r s t u v w x y zHow the study uses the data?
The study uses data from the FDA. It is based on isosorbide mononitrate and valganciclovir hydrochloride (the active ingredients of Imdur and Valcyte, respectively), and Imdur and Valcyte (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.
How to use the study?
DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.
Who is eHealthMe?
With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Could Cosopt cause Heart Attack? - 3 seconds ago
- Drug interactions of Amlodipine Besylate and Farydak - 3 seconds ago
- Drug interactions of Fentanyl and Zonisamide - 13 seconds ago
- Urinary Incontinence and Body Height Decreased - 19 seconds ago
- Thyroid Diseases and Hyperkalemia - 22 seconds ago
- Drug interactions of Tretinoin and Xeljanz Xr - 24 seconds ago
- Drug interactions of Adderall and Tolterodine - 27 seconds ago
- Could Tamsulosin cause Muscle Spasticity? - 27 seconds ago
- Drug interactions of Testosterone Cypionate and Valacyclovir - 28 seconds ago
- Could Synthroid cause Mononeuropathy? - 30 seconds ago